In the 2003 seminal paper, Al-Hajj et al identified CSCs in solid tumours by demonstrating tumorigenic (stem) cells with cell surface marker profile CD44+, CD24−/low in breast cancer (Al-Hajj et al., 2003). The gene discussed is CD44; the disease is breast carcinoma.